• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Thrombosis (2100)
Event Date 07/18/2020
Event Type  Injury  
Manufacturer Narrative
Patient identifier: (b)(6).
 
Event Description
(b)(6) study.It was reported that stent thrombosis and ischemia occurred.The subject underwent treatment with a study device on (b)(6) 2020 as part of the (b)(6) trial.The target lesion was located in left proximal superficial femoral artery (sfa) with 100% stenosis.The lesion was 100 mm long with a proximal reference vessel of 5 mm and a distal reference vessel diameter of 5 mm and was classified as a tasc ii a lesion.The target lesion was treated with pre-dilatation followed by placement of four 6 mm x 120 mm stents.Following post dilation, the residual stenosis was 0%.On (b)(6) 2020, the subject was discharged on dual antiplatelet therapy.On (b)(6) 2020, dissection flap in the target vessel.On (b)(6) 2020, the subject was hospitalized due to ischemia in left leg.Diagnosis revealed presence of thrombus in the stent.Subsequently, the subject also developed myocardial infarction for which medication was given as a treatment.No treatment was given for ischemia in target limb.On (b)(6) 2020, the subject died due to myocardial infarction unrelated to the stent.The event was considered not recovered/ not resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10718672
MDR Text Key212511085
Report Number2134265-2020-14557
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeBE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 10/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/10/2021
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0023737971
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/05/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/11/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-